{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:53:34Z","timestamp":1787828014978,"version":"build-2784847793"},"reference-count":11,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2017,6,30]]},"DOI":"10.3233\/jhd-170246","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T11:06:27Z","timestamp":1498820787000},"page":"149-156","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Participant Withdrawal in Huntington Disease Clinical Trials"],"prefix":"10.1177","volume":"6","author":[{"given":"Haruhiko","family":"Banno","sequence":"first","affiliation":[{"name":"Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Andrzejewski","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester, Rochester, NY, USA"},{"name":"Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA"},{"name":"Department of Neurology, Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Murphy","sequence":"additional","affiliation":[{"name":"Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhurima","family":"Majumder","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"de Blieck","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Auinger","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit E.","family":"Cudkowicz","sequence":"additional","affiliation":[{"name":"Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazem","family":"Atassi","sequence":"additional","affiliation":[{"name":"Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"6","key":"10.3233\/JHD-170246_ref1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9942","key":"10.3233\/JHD-170246_ref2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: Future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.3233\/JHD-170246_ref3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.3233\/JHD-170246_ref4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: A systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-170246_ref5","doi-asserted-by":"crossref","unstructured":"Unified Huntington\u2019s Disease Rating Scale: Reliability and consistency. Huntington Study Group. Mov Disord. 1996;11(2):136\u201342. doi: 10.1002\/mds.870110204","DOI":"10.1002\/mds.870110204"},{"key":"10.3233\/JHD-170246_ref6","doi-asserted-by":"crossref","unstructured":"Huntington Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology. 2001;57(3):397\u2013404.","DOI":"10.1212\/WNL.57.3.397"},{"issue":"13","key":"10.3233\/JHD-170246_ref7","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/mds.23236","article-title":"A futility study of minocycline in Huntington\u2019s disease","volume":"25","author":"Huntington Study Group DOMINO Investigators","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-170246_ref8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","article-title":"A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease","volume":"88","author":"McGarry","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.3233\/JHD-170246_ref9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/M15-0498","article-title":"Policy recommendations to guide the use of telemedicine in primary care settings: An American College of Physicians position paper","volume":"163","author":"Daniel","year":"2015","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.3233\/JHD-170246_ref10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.0b013e3182a823e0","article-title":"Analysis of start-up, retention, and adherence in ALS clinical trials","volume":"81","author":"Atassi","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JHD-170246_ref11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000329700","article-title":"Higher executive control and visual memory performance predict treatment completion in borderline personality disorder","volume":"81","author":"Fertuck","year":"2012","journal-title":"Psychother Psychosom"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-170246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:18Z","timestamp":1777453038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-170246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":11,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-170246","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]}}}